It’s been quite a week for American healthcare.
The current administration unveiled the first phase of their proposal to “repeal and replace” the Patient Protection and Affordable Care Act (ACA), currently titled the American Health Care Act (AHCA). The reveal has caused no end of concerns for patients, providers, and insurance carriers.
Evidence-based medicine and fee-for-performance programs must remain intact in order to advance the delivery of healthcare.
While there presently is no mention of eliminating either the value-based purchasing or bundled payment initiatives, we feel it is incumbent upon us to reiterate the importance of unbiased evidence and its role in the provision of cost-efficient, safe, and effective healthcare. The necessity of thoroughly scrutinized evidence, analyzed with scientific rigor and utilized to develop best practices, product standardization and utilization management is an incontrovertible fact. Providing treatment using unproven methods with inferior or expensive drugs and technologies will put patients at risk while continuing to push healthcare costs out of control.
Our mission is to transform healthcare with evidence. Facts will improve patient care and the cost of medicine. It is our hope that if the AHCA makes its way through our government process that the mission of keeping evidence-based medicine intact remains.
If you want to learn more about how we help payers and providers improve healthcare using evidence, sign up for personalized demo!